Use of lipid-lowering drugs in older adults with and without dementia: A community-based epidemiological study

Journal of the American Geriatrics Society

Volumn 50, Issue 11, 2002, Pages 1852-1856

  Rodriguez, Eric G ^a   Dodge, Hiroko H ^b   Birzescu, Maria A ^a   Stoehr, Gary P ^c   Ganguli, Mary ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Alzheimer's disease; Antilipemic drugs; Older people; Statins

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; COLESTIPOL; COLESTYRAMINE; FLUINDOSTATIN; GEMFIBROZIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; NICOTINIC ACID; PRAVASTATIN; SIMVASTATIN;

AGED; ALZHEIMER DISEASE; ANAMNESIS; ARTICLE; CONTROLLED STUDY; DEMENTIA; DISEASE CLASSIFICATION; DRUG UTILIZATION; EPIDEMIOLOGICAL DATA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; SCREENING; SELF REPORT;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTILIPEMIC AGENTS; COHORT STUDIES; DEMENTIA; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; PENNSYLVANIA; PHYSICIAN'S PRACTICE PATTERNS; RESIDENCE CHARACTERISTICS; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS;

EID: 0036842773     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1532-5415.2002.50515.x     Document Type: Article

References (30)

1. Wolozin B, Kellman W, Rousseau P et al. Decreased prevalence of Alzheimer's disease associated with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Arch Neurol 2000;57:1439-1443.
2. Jick H, Zornberg GL, Jick SS et al. Statins and the risk of dementia. Lancet 2000;356:1627-1631.
3. Ganguli M, Lytle M, Reynolds MD er al. Random vs volunteer selection for a community-based study. J Gerontol A Biol Sci Med Sci 1998;53A:M39-M46.
4. Lassila HC, Stoehr GP, Ganguli M et al. Use of prescription medications in an elderly rural population. The Movies Project. Ann Pharmacother 1996;30:589-595.
5. Stoehr G, Ganguli M, Seaberg EC et al. Over-the-counter medication use in a rural elderly community: The MoVIES project. J Am Geriatr Soc 1997;45:158-165.
6. Morris JC, Heyman A, Mohs RC et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39:1159-1165.
7. Folstein M, Folstein SE, McHugh PR. "Mini-Mental State". A practical method of grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
8. Ganguli M, Dodge HH, Chen P et al. Ten-year incidence of dementia in a rural elderly U.S. community population. The MoVIES Project. Neurology 2000;54:1109-1116.
9. Hughes CP, Berg L, Danziger WL et al. A new scale for the staging of dementia. BrJ Psychiatry 1982;140:566-572.
10. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley & Sons, 1989.
11. Notkola I-L, Sulkava R, Pekkanen J et al. Serum total cholesterol, apolipoprotein E e4 allele, and Alzheimer's disease. Neuroepidemiology 1998;17:14-20.
12. Meyer JS, Rauch GM, Crawford K et al. Risk factors accelerating cerebral degenerative changes, cognitive decline and dementia. Int J Geriatr Psychiatr 1999;14:1050-1061.
13. Moroney JT, Tang M-X, Berglund L et al. Low-density lipoprotein cholesterol and the risk of dementia with stroke. JAMA 1999;282:254-260.
14. Prospective Studies Collaboration. Cholesterol, diastolic blood pressure, and stroke: 13,000 Strokes in 450,000 people in 45 prospective cohorts. Lancet 1995;346:1647-1653.
15. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4,444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-1389.
16. Gambassi G, Landi F, Lapane KL et al. Is drug use in the elderly with cognitive impairment influenced by type of dementia? Pharmacotherapy, 1999;19:430-436.
17. McKhann G, Drachman D, Folstein M et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
18. Sparks DL, Martin TA, Gross DR et al. Links between heart disease, cholesterol and Alzheimer's disease: A review. Microsc Res Tech 2000;50:287-290.
19. Redelmeier DA, Siew HT, Booth GL. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med 1998;38:1516-1520.
20. Silverman M, McDowell BJ, Musa D et al. To treat or not to treat. Issues in decisions not to treat older persons with cognitive impairment, depression, and incontinence. J Am Geriatr Soc 1997;45:1094-1101.
21. Brauner DJ, Muir JC, Sachs GA. Treating nondementia illnesses in patients with dementia. JAMA 2000;283:3230-3235.
22. Post SG, Whitehouse PJ. Emerging antidementia drugs A preliminary ethical view. J Am Geriatr Soc 1998;46:784-787.
23. Morrison RS, Siu AL. Survival in end-stage dementia following acute illness. JAMA 2000;284:47-52.
24. Ryynanen OP, Myllykangas M, Kinnunen J et al. Prioritization attitudes among doctors and nurses examined by a scenario method. Int J Technol Assess Health Care 2000;16:92-99.
25. Schmader KE, Hanlon JT, Fillenbaum GG et al. Medication use patterns among demented, cognitively impaired and cognitively intact communitydwelling elderly people. Age Ageing 1998;27:493-501.
26. Semla TP, Cohen D, Paveza G et al. Drug use patterns of people with Alzheimer's disease and related disorders living in the community J Am Geriatr Soc 1993;41:408-413.
27. Mendelson G, Aronow WS. Underutilization of measurement of serum low-density lipoprotein cholesterol levels and of lipid-lowering therapy in older patients with manifest atherosclerotic disease. J Am Geriatr Soc 1998;46:1128-1131.
28. Moroney JT, Tseng CL, Paik MC et al. Treatment for the secondary prevention of stroke in older patients: The influence of dementia status. J Am Geriatr Soc 1999;47:824-829.
29. Cooper B, Bickel H, Schaufele M. The ability of general practitioners to detect dementia and cognitive impairment in their elderly patients: A study in Mannheim. IntJ Geriatric Psychiatry 1992;7:591-593.
30. Callahan CM, Hendrie HC Tierney WM. Documentation and evaluation of cognitive impairment in elderly primary care patients. Ann Intern Med 1995;122:422-429.